AVMXY News and Press, Avita Medical From 07/13/19

by Daniel Shvartsman The first half of 2019 saw a lot of green in the markets, as broader indices recovered from the brief bear market in the second half of 2018 and returned to new heights. Despite that, the wall of worry continued to grow, even if the specific concerns changed. Instead o...

Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced today favorable results from an open-la...

Regenerative medicine has made steady progress over the last few years, but, with few exceptions, little of that progress has been reflected in appreciating stock prices. From an investor’s mindset, there should be a balanced perspective that weighs the promise of explosive revenue grow...

Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces ...

Real world experience found that the RECELL System could save one US Burn Center up to USD $28MM annually AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that the health economic model of the U.S. burn care pathway, developed in collaboration with Biomedical Advanced Researc...

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced today that Dale A. Sander is resigning as Chief Financial Officer (CFO) to spend more time with his family on the east coast, effective immediately. Tim Rooney, AVITA’s Chief Administrative Offic...

AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that management will present at the RBC Capital Markets 2019 Healthcare Conference in New York. The presentation is being made on 21 May 2019 from 9:00 a.m. to 9:25 a.m. EDT at the InterContinental New ...

Recent Highlights Strong U.S. product sales of A$2.2 million for third quarter of Fiscal 2019 were double second quarter sales Ten presentations highlighting RECELL® System additional clinical and economic benefits featured at American Burn Association (ABA) 51 st Ann...

Professor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits, including reduced time to healing and decreased length of hospitalization The publication of the RECELL System pivotal trial in the tr...

Additional data presented at ABA Annual meeting include results demonstrating that donor sites treated using the RECELL System could be reharvested in as little as seven days after treatment Patients with burns covering more than 50% of their bodies treated using the RECELL System in c...